Immunovia Provides Complementary Information on the IMMray[™] PanCan-d Verification and Validation Studies
LUND, SWEDEN – Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced a necessary clarification to supplement the information shared on 26 October 2020 (link to press release ). About Blood Sample Inclusion Criteria It is standard practice to have specific inclusion criteria in place for the collection of blood samples for all diagnostic studies. Immunovia has always